Trials Sponsors Conditions Drugs Pricing

Conditions

Iliac Vein Occlusion Iliac Vein Stenosis

Keywords

Peripheral venous stent systemIliac vein patency rate

Outcome Measures

Primary Outcomes (1)

Target vascular patency rate at 12 months after operation
Target vascular patency rate
12 months

Secondary Outcomes (2)

The incidence of major adverse events
12 months
Adverse Event
Preoperative、Intraoperative、up to 1 month、3 month、6 month、12 month、2 years、3 years、5 years

Study Arms (2)

Zylox Peripheral Venous Stent Implantation

EXPERIMENTAL

Percutaneous stent placement in the iliofemoral veins

Device: Zylox Peripheral Venous Stent

Zilver Vena Venous Stent Implantation

ACTIVE COMPARATOR

Percutaneous stent placement in the iliofemoral veins

Device: Zilver Vena Venous Stent

Interventions

Zylox Peripheral Venous StentDevice

Self-expanding stent implantation during the index procedure.

Zylox Peripheral Venous Stent Implantation

Zilver Vena Venous StentDevice

Self-expanding stent implantation during the index procedure.

Zilver Vena Venous Stent Implantation

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 75 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Aged from 18 to 75 years old, male or female
Subject's target lesions were stenosis and/or occlusion

Sponsors & Collaborators

Zhejiang Zylox Medical Device Co., Ltd.
Industrylead

Study Sites (1)

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Related Publications (1)

Liu H, Zeng Q, Li F, Wang X, Teng B, Zhao Y. Comparison of the Zylox Penguin Venous Stent System and Zilver Vena Stent for Non-thrombotic Iliac Vein Lesions: A Multicentre Randomised Controlled Trial. Eur J Vasc Endovasc Surg. 2026 Feb 25:S1078-5884(26)00198-X. doi: 10.1016/j.ejvs.2026.02.043. Online ahead of print.
PMID: 41759711DERIVED

Study Officials

Yu Zhao
First Affiliated Hospital of Chongqing Medical University
PRINCIPAL INVESTIGATOR

Enrollment

220 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: PARTICIPANT
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

November 3, 2020

First Posted

March 23, 2021

Study Start

October 9, 2020

Actual (reported)

Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (2)

Zylox Peripheral Venous Stent Implantation

Zilver Vena Venous Stent Implantation

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (2)

Zylox Peripheral Venous Stent Implantation

Zilver Vena Venous Stent Implantation

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations